Ulcerative Colitis Clinical Trials in Houston

Showing 81-100 of 598 trials

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy

NCT06528093

This study is open to adults with advanced pancreatic cancer for whom previous treatment was not successful or no treatment exists. The purpose of this study is to find the highest dose of BI 765883 that people with advanced pancreatic cancer can tolerate when taken alone or together with chemotherapy. Another purpose is to check whether BI 765883 helps people with advanced pancreatic cancer. In this study, BI 765883 is given to humans for the first time. Participants receive either BI 765883 alone or BI 765883 in combination with chemotherapy. Participants can stay in the study as long as they benefit from treatment and can tolerate it. At study visits, doctors collect information on any health problems of the participants and check the severity of participants' cancer.

Pancreatic Ductal Adenocarcinoma

Boehringer Ingelheim8 participantsStarted Oct 2024

Denver, Colorado, United States • New Haven, Connecticut, United States • Sarasota, Florida, United States +14 more locations

Active Not RecruitingPhase 3< 1 mile

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

NCT06081894

This clinical trial will study the effects of aficamten (versus placebo) on the quality of life, exercise capacity, and clinical outcomes of patients with non-obstructive hypertrophic cardiomyopathy.

Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy

Cytokinetics500 participantsStarted Aug 2023

Birmingham, Alabama, United States • La Jolla, California, United States • Los Angeles, California, United States +177 more locations

A Study to Find a Suitable Dose of BI 765883 and to Test Whether it Helps People With Advanced Pancreatic Cancer When Taken Alone or Together With Chemotherapy

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM

Ulcerative Colitis Trials in Other Cities

A Study of PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Assessment of CCM in HF With Higher Ejection Fraction

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

A Study of Vericiguat (MK-1242) in Participants With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-035)

An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis

Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

COMPASSION S3 Post-Approval Study

Expanded Access Protocol for Boys With Duchenne Muscular Dystrophy

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean Study

Pancreatic Cancer Detection Consortium

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Other Conditions in Houston